PL2846774T3 - Kompozycja farmaceutyczna do leczenia dystrofii mięśniowej Duchenne'a - Google Patents
Kompozycja farmaceutyczna do leczenia dystrofii mięśniowej Duchenne'aInfo
- Publication number
- PL2846774T3 PL2846774T3 PL13726699T PL13726699T PL2846774T3 PL 2846774 T3 PL2846774 T3 PL 2846774T3 PL 13726699 T PL13726699 T PL 13726699T PL 13726699 T PL13726699 T PL 13726699T PL 2846774 T3 PL2846774 T3 PL 2846774T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- pharmaceutical composition
- muscular dystrophy
- duchenne muscular
- duchenne
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1208178.2A GB201208178D0 (en) | 2012-05-10 | 2012-05-10 | Pharmaceutical composition for the treatment of duchenne muscular dystrophy |
EP13726699.5A EP2846774B1 (en) | 2012-05-10 | 2013-05-10 | Pharmaceutical composition for the treatment of duchenne muscular dystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2846774T3 true PL2846774T3 (pl) | 2017-07-31 |
Family
ID=46396796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13726699T PL2846774T3 (pl) | 2012-05-10 | 2013-05-10 | Kompozycja farmaceutyczna do leczenia dystrofii mięśniowej Duchenne'a |
Country Status (14)
Country | Link |
---|---|
US (1) | US9492433B2 (pl) |
EP (1) | EP2846774B1 (pl) |
CY (1) | CY1118703T1 (pl) |
DK (1) | DK2846774T3 (pl) |
ES (1) | ES2617954T3 (pl) |
GB (1) | GB201208178D0 (pl) |
HR (1) | HRP20170143T1 (pl) |
HU (1) | HUE030416T2 (pl) |
LT (1) | LT2846774T (pl) |
PL (1) | PL2846774T3 (pl) |
PT (1) | PT2846774T (pl) |
RS (1) | RS55643B1 (pl) |
SI (1) | SI2846774T1 (pl) |
WO (1) | WO2013167737A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201412010D0 (en) | 2014-07-04 | 2014-08-20 | Summit Corp Plc | Treatment of hypertransaminasemia |
EP3500245A1 (en) | 2016-03-30 | 2019-06-26 | Summit (Oxford) Limited | Composition for the treatment of duchenne muscular dystrophy |
WO2018236879A1 (en) | 2017-06-19 | 2018-12-27 | University Of Maryland, Baltimore | INHIBITORS OF MICROTUBULAR POLYMERIZATION PRODRUGS AND METHODS OF USE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0707719A2 (pt) | 2006-02-10 | 2011-05-10 | Summit Corp Plc | uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo |
PE20090510A1 (es) | 2007-08-03 | 2009-05-22 | Summit Corp Plc | Combinaciones de drogas para el tratamiento de la distrofia muscular de duchenne |
GB0715937D0 (en) | 2007-08-15 | 2007-09-26 | Vastox Plc | Method of treatment og duchenne muscular dystrophy |
-
2012
- 2012-05-10 GB GBGB1208178.2A patent/GB201208178D0/en not_active Ceased
-
2013
- 2013-05-10 PT PT137266995T patent/PT2846774T/pt unknown
- 2013-05-10 ES ES13726699.5T patent/ES2617954T3/es active Active
- 2013-05-10 WO PCT/EP2013/059730 patent/WO2013167737A1/en active Application Filing
- 2013-05-10 HU HUE13726699A patent/HUE030416T2/en unknown
- 2013-05-10 RS RS20170092A patent/RS55643B1/sr unknown
- 2013-05-10 PL PL13726699T patent/PL2846774T3/pl unknown
- 2013-05-10 SI SI201330497A patent/SI2846774T1/sl unknown
- 2013-05-10 LT LTEP13726699.5T patent/LT2846774T/lt unknown
- 2013-05-10 DK DK13726699.5T patent/DK2846774T3/en active
- 2013-05-10 EP EP13726699.5A patent/EP2846774B1/en active Active
-
2014
- 2014-11-10 US US14/537,764 patent/US9492433B2/en not_active Expired - Fee Related
-
2017
- 2017-01-30 HR HRP20170143TT patent/HRP20170143T1/hr unknown
- 2017-02-08 CY CY20171100173T patent/CY1118703T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT2846774T (pt) | 2017-03-02 |
US20150238467A1 (en) | 2015-08-27 |
HUE030416T2 (en) | 2017-05-29 |
CY1118703T1 (el) | 2018-03-07 |
GB201208178D0 (en) | 2012-06-20 |
ES2617954T3 (es) | 2017-06-20 |
US9492433B2 (en) | 2016-11-15 |
RS55643B1 (sr) | 2017-06-30 |
HRP20170143T1 (hr) | 2017-04-21 |
EP2846774A1 (en) | 2015-03-18 |
DK2846774T3 (en) | 2017-02-13 |
WO2013167737A1 (en) | 2013-11-14 |
LT2846774T (lt) | 2017-03-10 |
SI2846774T1 (sl) | 2017-05-31 |
EP2846774B1 (en) | 2016-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209456A1 (en) | Oligonucleotide for the treatment of muscular dystrophy patients | |
HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
PT2818482T (pt) | Composição farmacêutica para o tratamento de cancro | |
PL2824114T3 (pl) | Kompozycja farmaceutyczna do leczenia nowotworu | |
ZA201501930B (en) | Pharmaceutical composition | |
EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
HK1199821A1 (en) | Oral pharmaceutical composition | |
HK1199822A1 (zh) | 口服給藥用醫藥組合物 | |
PL3524260T3 (pl) | Kompozycje farmaceutyczne do leczenia braku apetytu | |
PT2846774T (pt) | Composição farmacêutica para o tratamento da distrofia muscular de duchenne | |
ZA201502987B (en) | Pharmaceutical composition | |
EP2897590A4 (en) | PHARMACEUTICAL COMPOSITION | |
HK1204945A1 (en) | Pharmaceutical formulation containing flupirtin | |
EP2851078A4 (en) | PHARMACEUTICAL COMPOSITION | |
HUP1200552A2 (en) | Pharmaceutical compositions for the treatment of high blood pressure | |
GB201215527D0 (en) | Compounds for the treatment of muscular dystrophy | |
SI2812351T1 (sl) | Farmacevtski sestavek za zdravljenje multiple skleroze | |
GB201207476D0 (en) | pharmaceutical for the treatment of leishmaniasis | |
ZA201400751B (en) | Pharmaceutical composition | |
HUE043019T2 (hu) | Gyógyszerészeti készítmények kombinációs terápia céljára | |
GB201207628D0 (en) | New pharmaceutical composition | |
GB201207701D0 (en) | New pharmaceutical composition |